Blog

Seeing Solids Clearly—Beyond Powder Patterns with Single-Crystal X-ray Diffraction for Polymorphs, Hydrates, and IP Confidence: How Improved Pharma Uses SCXRD

2025-10-07T17:28:23+00:00

Single-crystal X-ray diffraction (SCXRD) provides the most definitive structural picture of pharmaceutical solids. From a single crystal, we obtain the unit cell, space group, and full atomic coordinates, which reveal hydrogen-bonding networks, π–π (ring) Read more

Seeing Solids Clearly—Beyond Powder Patterns with Single-Crystal X-ray Diffraction for Polymorphs, Hydrates, and IP Confidence: How Improved Pharma Uses SCXRD2025-10-07T17:28:23+00:00

Solid State Chemistry of Long-Acting Injectable Suspensions

2025-09-25T23:44:32+00:00

Solid State Chemistry of Long-Acting Injectable Suspensions Steve Byrn September 1, 2025 The Enduring Impact of Long-Acting Injectable Suspensions in Medicine Long-acting injectable (LAI) suspensions play a crucial role in modern drug delivery, offering Read more

Solid State Chemistry of Long-Acting Injectable Suspensions2025-09-25T23:44:32+00:00

Process and Method Validation in IND Drug Development: Building a Robust Foundation

2025-08-26T18:18:37+00:00

In our last blog, we explored the importance of control strategies during early pharmaceutical development. However, two additional elements critical to early-stage Investigational New Drug (IND) applications deserve special attention: process validation and method Read more

Process and Method Validation in IND Drug Development: Building a Robust Foundation2025-08-26T18:18:37+00:00

Achieving Control in IND Drug Development: Improved Pharma’s Comprehensive Strategy

2025-04-21T18:31:03+00:00

Achieving control is essential in early-stage pharmaceutical development, not only to meet regulatory expectations but to ensure consistency, high-quality, and reliability of clinical batches. Improved Pharma has developed a comprehensive control strategy that supports Read more

Achieving Control in IND Drug Development: Improved Pharma’s Comprehensive Strategy2025-04-21T18:31:03+00:00

Report on Benmore-Wilke Method for Structure Determination of Co-Processed ASD

2024-07-29T17:23:26+00:00

Dr. Chris Benmore of Argonne National Laboratory delivered an insightful talk at the 4th Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction Workshop held June 10-11, 2024, at the Novartis campus in Basel, Switzerland. His presentation Read more

Report on Benmore-Wilke Method for Structure Determination of Co-Processed ASD2024-07-29T17:23:26+00:00

Report on Co-Processing Plenary Lectures at the SPS-XRPD-4 Workshop

2024-07-22T17:19:41+00:00

The 4th Spring Pharmaceutical Synchrotron X-Ray Powder Diffraction Workshop was held June 10-11, 2024, at the Novartis campus in Basel, Switzerland. The SPS-XRPD workshops are a collaborative effort between Excelsus Structural Solutions in Switzerland Read more

Report on Co-Processing Plenary Lectures at the SPS-XRPD-4 Workshop2024-07-22T17:19:41+00:00

Using Optical Microscopy, Hot Stage Microscopy, and DSC Microscopy for Co-Processing Strategies – By Steve Byrn and Dale Purcell

2024-07-14T21:36:22+00:00

This blog focuses on how microscopy, hot-stage microscopy, and DSC microscopy can be used to develop co-processing strategies and relies heavily on input from Chemical Microscopy LLC, which is closely linked to Improved Pharma. Read more

Using Optical Microscopy, Hot Stage Microscopy, and DSC Microscopy for Co-Processing Strategies – By Steve Byrn and Dale Purcell2024-07-14T21:36:22+00:00

Analytical Methods for Studying Co-processed Pharmaceutical Solids – By Steve Byrn

2024-05-30T16:17:05+00:00

Our first blog post on co-processed pharmaceutical solids provided a general introduction. A second blog discussed an approach to screening for co-processed pharmaceutical solids. This third blog focuses on analytical methods for studying co-processed Read more

Analytical Methods for Studying Co-processed Pharmaceutical Solids – By Steve Byrn2024-05-30T16:17:05+00:00
Go to Top